![Chemical structure of Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-, CAS 113665-84-2](https://api.angenesci.com/structure/1842/113665-84-2.png)
无数据
无数据
无数据
| CAS Number | 113665-84-2 |
| Catalog Number | AG00099Q(AGN-PC-0P56S4) |
| Chemical Name | Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)- |
| IUPAC Name | methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate |
| InChI | InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1 |
| InChI Key | GKTWGGQPFAXNFI-HNNXBMFYSA-N |
| MDL Number | MFCD05662337 |
| Molecular Formula | C16H16ClNO2S |
| Molecular Weight | 321.8217 |
| NSC Number | 748298 |
| SMILES | ClC1=C(C=CC=C1)[C@@H](C(=O)OC)N1CC2=C(CC1)SC=C2 |
| UNII | A74586SNO7 |
| Synonyms | clopidogrel,
clopidogrel besilate,
clopidogrel besylate,
clopidogrel bisulfate,
clopidogrel hydrochloride,
Clopidogrel Mepha,
clopidogrel napadisilate,
clopidogrel Sandoz,
clopidogrel, (+)(S)-isomer,
clopidogrel-Mepha,
Iscover,
PCR 4099,
PCR-4099,
Plavix,
SC 25989C,
SC 25990C,
SR 25989,
clopidogrel,
113665-84-2,
(S)-Clopidogrel,
Plavix,
(+)-(S)-Clopidogrel,
Clopidogrel [INN:BAN],
(+)-Clopidogrel,
UNII-A74586SNO7,
HSDB 7430,
CLOPIDOGREL SULFATE,
CHEBI:37941,
GKTWGGQPFAXNFI-HNNXBMFYSA-N,
A74586SNO7,
CPD000550475,
Zyllt,
Clopidogrel (TN),
Plavix (TN),
SR-25990C,
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate,
Clopidogrelum,
Thrombo,
Clopidogrel BMS,
Clopidogrel Acino,
Clopidogrel Hexal,
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate,
CHEMBL1083385,
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate,
methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate,
(+)-(S)-Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c ] pyridin-5-yl) acetate monosulfate,
SMR000550475,
Thieno(3,2-c)pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (S)-,
Clopidogrel Winthrop,
Clopidogrel 1A Pharma,
Clopidogrel [BAN:INN],
120202-66-6,
Clopidogrel ratiopharm GmbH,
Isocover,
Plavix®,
(+) clopidogrel,
CGE,
Clopidogrel Teva (hydrogen sulphate),
Spectrum_000105,
SR 25990,
AC1L1TKZ,
Clopidogrel (USP/INN),
Spectrum2_000512,
Spectrum3_001606,
Spectrum4_000175,
SCHEMBL4769,
CHEMBL1771,
BSPBio_003211,
KBioGR_000689,
KBioSS_000545,
MLS001165708,
MLS001195633,
MLS001304711,
MLS006011891,
BIDD:GT0284,
clopidogrel, (+)(S)-isomer,
DivK1c_000787,
R 130964,
SPBio_000463,
AC1Q41I9,
GTPL7150,
DTXSID6022848,
CTK6I6432,
HMS502H09,
KBio1_000787,
KBio2_000545,
KBio2_003113,
KBio2_005681,
KBio3_002431,
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate,
NINDS_000787,
HMS2090O21,
HMS2234N16,
HMS3259B08,
HMS3715J08,
Clopidogrel USP Related Compound A,
KS-00000K9F,
BBL010770,
BDBM50318910,
BDBM50397662,
CC0015,
MFCD00866627,
MFCD05662337,
NSC748298,
STK580572,
ZINC34781704,
AKOS005504280,
API0002073,
CCG-221243,
CS-0656,
DB00758,
MCULE-9061369538,
NC00703,
NSC-748298,
IDI1_000787,
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate,
NCGC00163329-02,
NCGC00163329-04,
AC-19024,
AJ-90179,
DS-13362,
HY-15283,
SAM002589956,
SBI-0052755.P002,
AB1011824,
LS-172232,
RT-012071,
TL8000400,
FT-0602596,
D07729,
W-5322,
AB00053786-07,
AB00053786-08,
AB00053786_09,
AB00053786_10,
BRD-K27721098-065-02-9,
BRD-K27721098-065-05-2,
methyl (2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate,
(S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate,
(S)-(+)-Methyl (2-chlorophenyl)-(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate,
methyl (+)-(S)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate,
methyl (+)-(s)-alpha-(o-chlorophenyl)-6,7-dihydrothieno-[3,2-c]pyridine-5(4h)-acetate,
Methyl (2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate (H2SO4),
methyl (S)-(+)-alpha-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-acetate,
methyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate,
methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate,
methyl-(S)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridine-5-yl)-acetate,
(+)-(S)-(2-Chlorophenyl) (6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetic acid methyl ester,
(+)-(S)-2-(2-chlorophenyl)-(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetic acid methyl ester,
(S)-METHYL 2-(2-CHLOROPHENYL)-2-(6,7-DIHYDROTHIENO[3,2-C]PYRIDINE-5(4H)-YL)ACETATE,
Iscover; Plavix; methyl (S)-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)acetate; clopidogrel; 2-(2-chlorphenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3, 2c]pyridine-5yl)-acetic acid methylester hydrogen sulfate,
Thieno[3,2-c]pyridine-5(4H)-acetic acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (.alpha.S)-,
Thieno[3,2-c]pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (alphaS)-,
Iscover,
clopidogrel HCl,
Clopidogrel bisulfate,
Clopidogrel HCS,
Clopidogrel besilate,
Clopidogrel hydrobromide,
Clopidogrel bisulphate,
Clopidogrel hydrochloride,
Clopidogrel impurity A,
D0N0TZ,
C16H16ClNO2S,
clopidogrel hydrogen sulphate,
Clopidogrel (captisol-enabled),
C16-H16-Cl-N-O2-S,
CID60606,
SR25990C,
PM-103,
ACN-048231,
CS-O-15507,
1705B,
Clopidogrel (captisol-enabled), The Medicines Co,
90055-48-4,
Clopidogrel (captisol-enabled, cardiovascular disease), Cydex,
144750-42-5,
Clopidogrel (captisol-enabled, cardiovascular disease), Prism Pharmaceuticals,
methyl (+)-(S)alpha-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate,
(alpha S)-alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester,
|
| Complexity | 381 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 321.059g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 21 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 321.819g/mol |
| Monoisotopic Mass | 321.059g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 57.8A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.8 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

